Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Laboratory Corporation of America Stock Quote

Laboratory Corporation of America (NYSE: LH)

Price as of December 5, 2023, 12:16 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Laboratory Corporation of America Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
LH +6.97% +80.30% +12.50% +8,007%
S&P +12.71% +66.46% +10.72% +778%

Laboratory Corporation of America Company Info

Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC.

News & Analysis

The Fool has written over 100 articles on Laboratory Corporation of America.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.